NOEMU vs CCRN

CO2 Energy Transition Corp.

Unit (NOEMU) offers the better valuation at 9999. 0x trailing P/E, making it the more compelling value choice. Analysts rate Cross Country Healthcare, Inc. (CCRN) a "Hold" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, CO2 Energy Transition Corp.

Unit (NOEMU) delivered a total return of +6. 1%, compared to -22. 5% for Cross Country Healthcare, Inc. (CCRN). Over 10 years, the gap is even starker: NOEMU returned +6. 1% versus CCRN's -10. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CO2 Energy Transition Corp.

Unit (NOEMU) is the lower-risk stock at -0. 04β versus Cross Country Healthcare, Inc. 's 0. 78β — meaning CCRN is approximately -1976% more volatile than NOEMU relative to the S&P 500. On balance sheet safety, CO2 Energy Transition Corp. Unit (NOEMU) carries a lower debt/equity ratio of 0% versus 1% for Cross Country Healthcare, Inc. — giving it more financial flexibility in a downturn.

On earnings-per-share growth, the picture is similar: CO2 Energy Transition Corp.

Unit grew EPS 100. 3% year-over-year, compared to -565. 9% for Cross Country Healthcare, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CO2 Energy Transition Corp.

Unit (NOEMU) is the more profitable company, earning 0. 0% net margin versus -9. 0% for Cross Country Healthcare, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NOEMU leads at 0. 0% versus -0. 3% for CCRN. At the gross margin level — before operating expenses — CCRN leads at 18. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, CO2 Energy Transition Corp.

Unit (NOEMU) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04)). Both have compounded well over 10 years (NOEMU: +6. 1%, CCRN: -10. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (NOEMU (Financial Services) and CCRN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.